Home
Random
Nearby
Log in
Settings
Donate
About Wikidata
Disclaimers
Search
(Q54102626)
Watch
English
Great expectations for simtuzumab in IPF fall short.
scientific article
In more languages
edit
Statements
instance of
scholarly article
1 reference
stated in
Europe PubMed Central
PubMed publication ID
27939077
retrieved
24 May 2018
reference URL
http://europepmc.org/abstract/MED/27939077
title
Great expectations for simtuzumab in IPF fall short.
(English)
1 reference
stated in
Europe PubMed Central
PubMed publication ID
27939077
retrieved
24 May 2018
reference URL
http://europepmc.org/abstract/MED/27939077
author name string
Keith C Meyer
series ordinal
1
1 reference
stated in
Europe PubMed Central
PubMed publication ID
27939077
retrieved
24 May 2018
reference URL
http://europepmc.org/abstract/MED/27939077
publication date
7 December 2016
1 reference
stated in
Europe PubMed Central
PubMed publication ID
27939077
retrieved
24 May 2018
reference URL
http://europepmc.org/abstract/MED/27939077
published in
The Lancet. Respiratory medicine
1 reference
stated in
Europe PubMed Central
PubMed publication ID
27939077
retrieved
24 May 2018
reference URL
http://europepmc.org/abstract/MED/27939077
volume
5
1 reference
stated in
Europe PubMed Central
PubMed publication ID
27939077
retrieved
24 May 2018
reference URL
http://europepmc.org/abstract/MED/27939077
issue
1
1 reference
stated in
Europe PubMed Central
PubMed publication ID
27939077
retrieved
24 May 2018
reference URL
http://europepmc.org/abstract/MED/27939077
page(s)
2-3
1 reference
stated in
Europe PubMed Central
PubMed publication ID
27939077
retrieved
24 May 2018
reference URL
http://europepmc.org/abstract/MED/27939077
cites work
Effect of interferon gamma-1b on survival in patients with idiopathic pulmonary fibrosis (INSPIRE): a multicentre, randomised, placebo-controlled trial
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS2213-2600%2816%2930420-9
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
BUILD-3: a randomized, controlled trial of bosentan in idiopathic pulmonary fibrosis
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS2213-2600%2816%2930420-9
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Prednisone, azathioprine, and N-acetylcysteine for pulmonary fibrosis
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS2213-2600%2816%2930420-9
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Pirfenidone in idiopathic pulmonary fibrosis
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS2213-2600%2816%2930420-9
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
A phase 3 trial of pirfenidone in patients with idiopathic pulmonary fibrosis
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS2213-2600%2816%2930420-9
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Efficacy and safety of nintedanib in idiopathic pulmonary fibrosis
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS2213-2600%2816%2930420-9
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Lysyl oxidases: a novel multifunctional amine oxidase family
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS2213-2600%2816%2930420-9
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Lysyl oxidase: from basic science to future cancer treatment
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS2213-2600%2816%2930420-9
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Allosteric inhibition of lysyl oxidase–like-2 impedes the development of a pathologic microenvironment
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS2213-2600%2816%2930420-9
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Serum lysyl oxidase-like 2 levels and idiopathic pulmonary fibrosis disease progression
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS2213-2600%2816%2930420-9
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Precision Medicine: The New Frontier in Idiopathic Pulmonary Fibrosis
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS2213-2600%2816%2930420-9
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
IPF clinical trial design and endpoints
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS2213-2600%2816%2930420-9
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Identifiers
DOI
10.1016/S2213-2600(16)30420-9
1 reference
stated in
Europe PubMed Central
PubMed publication ID
27939077
retrieved
24 May 2018
reference URL
http://europepmc.org/abstract/MED/27939077
PubMed publication ID
27939077
1 reference
stated in
Europe PubMed Central
PubMed publication ID
27939077
retrieved
24 May 2018
reference URL
http://europepmc.org/abstract/MED/27939077
Sitelinks
Wikipedia
(0 entries)
edit
Wikibooks
(0 entries)
edit
Wikinews
(0 entries)
edit
Wikiquote
(0 entries)
edit
Wikisource
(0 entries)
edit
Wikiversity
(0 entries)
edit
Wikivoyage
(0 entries)
edit
Wiktionary
(0 entries)
edit
Multilingual sites
(0 entries)
edit
